These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1472351)
21. [HIV-2 and HTLV-1/2 infections in Spain]. Treviño A; Soriano V; Med Clin (Barc); 2010 Jun; 135(2):67-9. PubMed ID: 19560171 [No Abstract] [Full Text] [Related]
22. Retrospective study of transfusion-associated HIV infections in Switzerland. Bosshard H; Zwahlen M; Marti B; Frey-Wettstein M Lancet; 1994 Mar; 343(8900):797. PubMed ID: 7907757 [No Abstract] [Full Text] [Related]
23. Risk of transfusion-associated HIV transmission in Kinshasa, Zaire. N'tita I; Mulanga K; Dulat C; Lusamba D; Rehle T; Korte R; Jäger H AIDS; 1991 Apr; 5(4):437-9. PubMed ID: 2059386 [TBL] [Abstract][Full Text] [Related]
24. [Proposal for post-transfusional survey of neonates]. Terrache A; Kraim N; Quenum S; Hervé F Arch Pediatr; 2001 Apr; 8(4):444-5. PubMed ID: 11339137 [No Abstract] [Full Text] [Related]
25. Lack of evidence of HIV-2 infection among multitransfused thalassemic children in the city of New Delhi. Chattopadhya D; Aggarwal R; Kumari SS; Verghese T; Sen S J Trop Pediatr; 1996 Apr; 42(2):116-7. PubMed ID: 8984209 [No Abstract] [Full Text] [Related]
26. Transmission of HIV by transfusion of screened blood. Donahue JG; Nelson KE; Muñoz A; McAllister HA; Yawn DH; Ness PM; Cohen ND N Engl J Med; 1990 Dec; 323(24):1709. PubMed ID: 2233972 [No Abstract] [Full Text] [Related]
27. HIV testing and blood recipients. Hewitt PE Lancet; 1994 Mar; 343(8900):797-8. PubMed ID: 7907758 [No Abstract] [Full Text] [Related]
28. [2 cases of transfusional malaria. Attempted prevention combining an indirect immunofluorescence test with clinical selection critera]. Besson P; Robert JF; Reviron J; Richard-Lenoble D; Gentilini M Rev Fr Transfus Immunohematol; 1976 Jun; 19(2):369-73. PubMed ID: 790520 [No Abstract] [Full Text] [Related]
29. France: prison sentences for doctors. Bader JM Lancet; 1992 Oct; 340(8827):1087. PubMed ID: 1357465 [No Abstract] [Full Text] [Related]
30. Supreme court to hear appeal in negligence claim against Red Cross for HIV infection. Can HIV AIDS Policy Law Rev; 2000; 5(4):9. PubMed ID: 11833181 [No Abstract] [Full Text] [Related]
31. [Evaluation of pre- and post-transfusion serological screening in France in 2001]. Daurat G; Fressy P; Duedari N; Le Blanc G; Taverne D; Ounnoughène N; Pillonel J Transfus Clin Biol; 2004 Jul; 11(3):153-60. PubMed ID: 15488728 [TBL] [Abstract][Full Text] [Related]
33. Risk of HIV infection from blood transfusion. Salzberg AM BMJ; 1992 Nov; 305(6862):1159. PubMed ID: 1298245 [No Abstract] [Full Text] [Related]
34. HIV screening of blood transfusions in Zambia. Yikona J Lancet; 1995 Sep; 346(8976):707. PubMed ID: 7658850 [No Abstract] [Full Text] [Related]
35. Changes in HIV seroprevalence among blood donors in Benin City, Nigeria. Offor E; Okafor L; Osunde J AIDS; 1994 Sep; 8(9):1352-4. PubMed ID: 7802998 [No Abstract] [Full Text] [Related]
36. [Comments to the manuscript; HIV in Mexican blood donors and estimated transfusional risk]. Sánchez-Guerrero SA Rev Invest Clin; 2008; 60(6):545-6; author reply 547. PubMed ID: 19378840 [No Abstract] [Full Text] [Related]
37. Two successive HIV contaminations from subjects in the window period. Laperche S; Moreau P; Lair J; Couroucé AM AIDS; 1998 Jul; 12(11):1397-8. PubMed ID: 9708425 [No Abstract] [Full Text] [Related]
38. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety. McFarland W; Mvere D; Katzenstein D AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107 [TBL] [Abstract][Full Text] [Related]
39. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Zuck TF; Thomson RA; Schreiber GB; Gilcher RO; Kleinman SH; Murphy EL; Ownby HE; Williams AE; Busch MP; Smith JW Transfusion; 1995; 35(11):944-51. PubMed ID: 8604493 [No Abstract] [Full Text] [Related]
40. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Kleinman S; Busch MP; Korelitz JJ; Schreiber GB Transfus Med Rev; 1997 Jul; 11(3):155-72. PubMed ID: 9243769 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]